
Company valuation, historical trends, and peer comparisons.
According to Odyssey Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 859.75M. This represents a change of 34.94% compared to the average of 637.14M of the last 4 quarters.
The mean historical Enterprise Value of Odyssey Therapeutics, Inc. over the last ten years is 437.98M. The current 859.75M Enterprise Value has changed 96.30% with respect to the historical average. Over the past ten years (40 quarters), ODTX's Enterprise Value was at its highest in in the March 2026 quarter at 765.01M. The Enterprise Value was at its lowest in in the June 2026 quarter at 509.28M.
Average
437.98M
Median
437.98M
Minimum
437.98M
Maximum
437.98M
Discovering the peaks and valleys of Odyssey Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 437.98M
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 437.98M
| Year | Enterprise Value | Change |
|---|
The current Enterprise Value of Odyssey Therapeutics, Inc. (ODTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
437.98M
5-year avg
437.98M
10-year avg
437.98M
Odyssey Therapeutics, Inc.’s Enterprise Value is less than AnaptysBio, Inc. (1.57B), greater than Immunic, Inc. (-56017955.00), less than Spyre Therapeutics, Inc. (8.36B), greater than Aclaris Therapeutics, Inc. (544.60M), greater than Alumis Inc. (855.47M), less than Oruka Therapeutics, Inc. (5.11B), less than Protagonist Therapeutics, Inc. (8.62B), greater than AgomAb Therapeutics N.V. American Depositary Shares (186.70M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.57B | $1.44B | |
| -56017955.00 | $98.51M | |
| 8.36B | $8.52B | |
| 544.60M | $563.77M | |
| 855.47M | $882.75M | |
| 5.11B | $5.37B | |
| 8.62B | $9.03B | |
| 186.70M | $456.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Odyssey Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Odyssey Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Odyssey Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Odyssey Therapeutics, Inc. (ODTX)?
What is the 3-year average Enterprise Value for Odyssey Therapeutics, Inc. (ODTX)?
What is the 5-year average Enterprise Value for Odyssey Therapeutics, Inc. (ODTX)?
How does the current Enterprise Value for Odyssey Therapeutics, Inc. (ODTX) compare to its historical average?